Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy.
Ogawa K, Nishizawa K, Washiyama K, Munekane M, Fuchigami T, Echigo H, Mishiro K, Hirata S, Wakabayashi H, Takahashi K, Kinuya S.
Ogawa K, et al. Among authors: takahashi k.
Nucl Med Biol. 2023 Jul-Aug;122-123:108369. doi: 10.1016/j.nucmedbio.2023.108369. Epub 2023 Jul 22.
Nucl Med Biol. 2023.
PMID: 37516066